Search results
Pharming's Leniolisib Goes Under Priority FDA Review For Rare Immune System Disorder
Benzinga via Yahoo Finance· 2 years agoThe FDA has accepted Pharming Group NV's (NASDAQ: PHAR) marketing application seeking approval for...
US FDA approves Pharming's immune disorder drug
Reuters via Yahoo News· 1 year ago(Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Pharming Group's drug to treat a rare genetic disorder that leads to a weakened...
Pharming Highlights Interim Data From Rare Immune Deficiency Study
Benzinga via Yahoo Finance· 1 year agoPharming Group N.V. (NASDAQ: PHAR) announced data from an interim analysis of its open-label...
FDA Approves Pharming's Immune Disorder Drug, As First APDS Therapy
Benzinga via Yahoo Finance· 1 year agoThe FDA approved Pharming Group N.V.'s (NASDAQ: PHAR) Joenja (leniolisib) for activated...
Director Adelene Perkins Sells 410,196 Shares of Infinity Pharmaceuticals Inc (INFI)
GuruFocus.com via Yahoo Finance· 7 months agoOn September 12, 2023, Adelene Perkins, a director at Infinity Pharmaceuticals Inc, sold 410,196...
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 7 days agoPharming Group (PHAR) saw its shares surge in the last session with trading volume being higher than...
Pharming (PHAR) Rare Disease Drug Joenja Gets FDA Nod, Stock Up
Zacks via Yahoo Finance· 1 year agoPharming Group (PHAR) obtains FDA approval for leniolisib for the treatment of a rare pediatric...